In fact, Lan and colleagues found that simultaneous targeting of TGFβ and PD-L1, in combination with radiotherapy, prolonged survival in mouse models of several cancers, including pancreatic cancer [108]. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.